![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/00 | |
A61K 39/395 | |||
C07K 16/00 | |||
C07K 16/18 | |||
C07K 16/28 | |||
A61K 47/68 | |||
A61P 35/00 |
(11) | Number of the document | 3038644 |
(13) | Kind of document | T |
(96) | European patent application number | 14839285.5 |
Date of filing the European patent application | 2014-08-28 | |
(97) | Date of publication of the European application | 2016-07-06 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/053310 |
Date | 2014-08-28 |
(87) | Number | WO 2015/031698 |
Date | 2015-03-05 |
(30) | Number | Date | Country code |
201361871173 P | 2013-08-28 | US | |
201361871289 P | 2013-08-28 | US | |
PCT/US2014/0530 | 2014-08-27 | WO |
(72) |
ARATHOON, William Robert, US
PADAWER, Ishai, US
CANO, Luis Antonio, US
SISODIYA, Vikram Natwarsinhji, US
MANI, Karthik Narayan, US
LIU, David, US
|
(73) |
AbbVie Stemcentrx LLC,
1 North Waukegan Road, North Chicago, IL 60064-6400,
US
|
(54) | SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS |
SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS |